Mandate

Vinge has advised InnKap 4 Partners L.P., in connection with an investment in PBM Sweden AB

December 11, 2009

Vinge has advised InnKap 4 Partners L.P., in connection with an investment in PBM Sweden AB. PBM Sweden AB and InnovationsKapital have entered into a long-term co-operation in which the fund, InnKap 4 Partners L.P., will invest approximately SEK 20 million in return for equity, shares and options.

PBM Sweden AB conducts scientifically-based vocational programmes and training focused on rehabilitation, management and organisational development. The part of the operation directed toward behavioural therapy focuses on improving the quality of life for people who suffer primarily from work and stress-related problems as well as increasing productivity through improved management and healthier employees. The company’s customer base includes county councils, insurance companies and private limited companies.

The Vinge team included responsible partner Malin Ohlin-Åkermark and associate Nina Farrahi.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025